Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor. Navitoclax-piperazine and a VHL ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC DT2216 Form:Solid IC50& Target:Bcl-xL
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Navitoclax-piperazine
CAS number:2143096-93-7 molecular formula:C47H56ClF3N6O5S3
overview
compound introduction
Specs
| Chinese alias | 纳维托克拉-哌嗪 | ||
| English alias | - | ||
| CAS number | 2143096-93-7 | molecular formula | C47H56ClF3N6O5S3 |
| molecular weight | 973.63 g/mol | Exact mass | ≥99% |
| PSA | 173.000 Ų | logp | 9.300 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





